BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 14594504)

  • 1. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
    Sovalat H; Racadot E; Ojeda M; Lewandowski H; Chabouté V; Hénon P
    J Hematother Stem Cell Res; 2003 Oct; 12(5):473-89. PubMed ID: 14594504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
    Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
    J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell adhesion molecules in cord blood hematopoietic progenitors.
    Timeus F; Crescenzio N; Marranca D; Dall'Aglio M; Fazio L; Di Marco M; Saracco P; Ricotti M; Gabutti V
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S61-2. PubMed ID: 9715892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference between expression of adhesion molecules on CD34+ cells from bone marrow and G-CSF-stimulated peripheral blood.
    Kröger N; Zeller W; Hassan HT; Dierlamm J; Zander AR
    Stem Cells; 1998; 16(1):49-53. PubMed ID: 9474747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells.
    Zeller W; Kröger N; Berger J; Krueger W; Dierlamm J; Stockschläder M; Gutensohn K; Hossfeld DK; Zander AR
    J Hematother Stem Cell Res; 1999 Oct; 8(5):539-46. PubMed ID: 10791904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery.
    Möhle R; Murea S; Kirsch M; Haas R
    Exp Hematol; 1995 Dec; 23(14):1535-42. PubMed ID: 8542944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
    Steen R; Tjønnfjord GE; Egeland T
    J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.
    Möhle R; Haas R; Hunstein W
    J Hematother; 1993; 2(4):483-9. PubMed ID: 7522108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy.
    Fruehauf S; Veldwijk MR; Krämer A; Haas R; Zeller WJ
    Stem Cells; 1998; 16(4):271-9. PubMed ID: 9708449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cell adhesion molecules by human hematopoietic progenitor cells from bone marrow and mobilized adult peripheral blood.
    Turner ML; McIlwaine K; Anthony RS; Parker AC
    Stem Cells; 1995 May; 13(3):311-6. PubMed ID: 7542116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of differentiation antigens and adhesion molecules on CD34+ cells in peripheral blood and bone marrow after chemotherapy followed by administration of granulocyte colony stimulating factor.
    Masauzi N
    Hokkaido Igaku Zasshi; 1996 Nov; 71(6):771-83. PubMed ID: 8996844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change of adhesion molecule expression on CD34(+) cells from bone marrow and peripheral blood during mobilization with combination of chemotherapy and G-CSF].
    Da WM; Zhang M; Zhang BL; Jin HJ; Yu L; Han XP; Jing Y; Zhao Y; Wu XX; Huang WR; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):240-2. PubMed ID: 12513794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
    Fruehauf S; Haas R; Conradt C; Murea S; Witt B; Möhle R; Hunstein W
    Blood; 1995 May; 85(9):2619-26. PubMed ID: 7537123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies.
    Dabusti M; Lanza F; Campioni D; Castagnari B; Tieghi A; Moretti S; Punturieri M; De Angeli C; Spanedda R; Ferrazzi E; Castoldi G
    J Hematother Stem Cell Res; 2003 Aug; 12(4):425-34. PubMed ID: 12965079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells.
    Saeland S; Duvert V; Caux C; Pandrau D; Favre C; Vallé A; Durand I; Charbord P; de Vries J; Banchereau J
    Exp Hematol; 1992 Jan; 20(1):24-33. PubMed ID: 1374342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.